UiPath Inc. (NYSE:PATH) Receives Consensus Recommendation of “Hold” from Analysts

UiPath Inc. (NYSE:PATH) has received a consensus recommendation of “Hold” from the eighteen ratings firms that are covering the stock, MarketBeat reports. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $17.94.

A number of analysts have recently commented on the company. Canaccord Genuity Group dropped their price objective on UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a research note on Friday, May 31st. Bank of America restated a “neutral” rating and set a $16.00 price target (down previously from $30.00) on shares of UiPath in a report on Thursday, May 30th. Truist Financial reaffirmed a “hold” rating and issued a $14.00 price objective (down previously from $32.00) on shares of UiPath in a research note on Thursday, May 30th. DA Davidson reduced their target price on UiPath from $24.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Finally, TD Cowen reiterated a “hold” rating and issued a $17.00 price objective (down previously from $28.00) on shares of UiPath in a research note on Thursday, May 30th.

Institutional Trading of UiPath

Hedge funds and other institutional investors have recently made changes to their positions in the company. Mark Sheptoff Financial Planning LLC bought a new stake in shares of UiPath in the fourth quarter worth $25,000. ORG Partners LLC grew its position in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of UiPath in the second quarter valued at about $28,000. Redwood Wealth Management Group LLC bought a new position in shares of UiPath during the second quarter worth about $43,000. Finally, Lindbrook Capital LLC lifted its stake in shares of UiPath by 46.0% in the first quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after acquiring an additional 639 shares during the period. 62.50% of the stock is currently owned by institutional investors.

UiPath Stock Performance

Shares of PATH opened at $12.74 on Friday. The firm has a fifty day moving average of $12.22 and a 200-day moving average of $16.80. UiPath has a 1 year low of $10.37 and a 1 year high of $27.87. The company has a market cap of $7.30 billion, a price-to-earnings ratio of -79.63 and a beta of 0.87.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.